Pharma Foods International Co., Ltd. (TYO:2929)

TYO:2929 Balance Sheet

Financials in millions JPY. Fiscal year is August - July.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Cash & Equivalents	7,791	9,157	15,666	16,306	8,845
Cash & Short-Term Investments	7,791	9,157	15,666	16,306	8,845
Cash Growth	-14.92%	-41.55%	-3.92%	84.35%	-9.69%
Receivables	3,990	5,285	4,294	4,582	7,425
Inventory	9,143	7,850	6,717	6,053	6,066
Other Current Assets	2,105	1,578	598	589	1,177
Total Current Assets	23,029	23,870	27,275	27,530	23,513
Property, Plant & Equipment	8,018	4,696	4,609	4,404	4,458
Long-Term Investments	3,352	3,446	4,159	3,663	2,881
Goodwill	37	71	124	197	270
Other Intangible Assets	48	49	53	41	35
Long-Term Deferred Tax Assets	630	515	351	395	-
Other Long-Term Assets	1	2	2	2	2
Total Assets	35,115	32,649	36,573	36,232	31,159

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Accounts Payable	1,413	1,923	1,250	937	1,176
Accrued Expenses	74	72	72	72	70
Short-Term Debt	13,400	11,400	14,900	17,400	15,400
Current Portion of Long-Term Debt	560	560	760	955	760
Current Income Taxes Payable	1,710	5,014	5,423	3,992	4,511
Other Current Liabilities	1,108	1,036	758	1,018	878
Total Current Liabilities	18,265	20,005	23,163	24,374	22,795
Long-Term Debt	3,211	671	1,231	1,741	697
Pension & Post-Retirement Benefits	374	378	384	320	427
Other Long-Term Liabilities	100	49	210	167	168
Total Liabilities	21,950	21,103	24,988	26,602	24,087

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Common Stock	2,043	2,043	2,043	2,043	2,042
Additional Paid-In Capital	1,814	1,814	1,814	1,814	1,820
Retained Earnings	8,969	7,691	8,356	5,792	3,300
Treasury Stock	-26	-195	-1,194	-343	-138
Comprehensive Income & Other	365	193	566	324	46
Total Common Equity	13,165	11,546	11,585	9,630	7,070
Minority Interest	-	-	-	-	2
Shareholders' Equity	13,165	11,546	11,585	9,630	7,072
Total Liabilities & Equity	35,115	32,649	36,573	36,232	31,159

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Total Debt	17,171	12,631	16,891	20,096	16,857
Net Cash (Debt)	-9,380	-3,474	-1,225	-3,790	-8,012
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-323.69	-120.87	-43.07	-131.25	-276.14
Filing Date Shares Outstanding	29.04	28.87	28.07	28.85	29.02
Total Common Shares Outstanding	29.04	28.87	28.07	28.85	29.02
Working Capital	4,764	3,865	4,112	3,156	718
Book Value Per Share	453.28	399.90	412.69	333.85	243.61
Tangible Book Value	13,080	11,426	11,408	9,392	6,765
Tangible Book Value Per Share	450.35	395.75	406.38	325.60	233.10
Order Backlog	-	600	1,012	1,558	1,300

Data Source: S&P Global Market Intelligence Last updated: Sep 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error